Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats

Summary:

In rats with streptozotocin (STZ) induced diabetes the effect of (watersoluble) thiamine nitrate and of (lipidsoluble) benfotiamine on peripheral nerve function (motor nerve conduction velocity) as well as on the formation of advanced glycation end-products in peripheral nerve tissue was studied. In one group of animals drug administration was started immediately after diabetes induction (prevention study) and in another group two months after diabetes induction (treatment study). Motor nerve conduction velocity (NCV) dropped by 10.5% in diabetic animals, carboxymethyl-lysine (CML) rose to a 3.5fold concentration, deoxyglucosone (3DG)-type AGE formation was increased 5.1fold compared with controls. After three months preventive administration of both vitamin B₁ preparations NCV had increased substantially compared with results in diabetic controls. It was nearly normal after six months with benfotiamine, while the administration of thiamine nitrate resulted in no further amelioration. NCV was nearly normalized after six months of benfotiamine application but not with thiamine. Furthermore, benfotiamine induced a major inhibition of neural imidazole-type AGE formation and completely prevented diabetes induced glycoxidation products (CML). Treatment with thiamine did not significantly affect AGE or cmL levels. Unlike treatment with water-soluble thiamine nitrate timely administration of liposoluble prodrug benfotiamine was effective in the prevention of functional damage and of AGE and cmL formation in nerves of diabetic rats.

Key words:

Diabetic (STZ) rats - nerve conduction velocity - nerve glycoxidation products - benfotiamine protection

References

• 1 Becker K W, Kienecker E-W, Dick P. A contribution to the scientific assessment of degenerative and regenerative processes in peripheral nerve fibers following axonotmesis under the systemic administration of vitamin B₁, B₆ and B₁₂ - light and electron microscopy findings in the saphenous nerve of the rabbit.  Neurochirurgia. 33 113-121 1990; 
• 2 Bitsch R, Wolf M, Müller J, Heuzeroth L, Grüneklee D. Bioavailability assessment of the lipophile benfotiamine compared to a water-soluble thiamine derivative.  Hum Nutr Metab. 35 292-296 1991; 
• 3 Bitsch J, Netzel M, Ziems M, Wenisch S. Untersuchungen zur neuroprotektiven Wirkung von Benfotiamin. In: Gries FA, Federlin K (Hrsg.) Benfotiamin in der Therapie von Polyneuropathien. Int. Sympos. Stuttgart. Thieme-Verlag : 35-39 1998
• 4 Both A A, Khalifah R G, Hudson B G. Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine.  Biochem Biophys Res Comm. 220 113-119 1996; 
• 5 Burnard S L, McMurchie E J, Leifert W R, Patten G S, Muggli R, Raederstorff D, Head R J. Cilazapril and dietary gamma-linolenic acid prevent the deficit in sciatic nerve conduction velocity in the streptozotocin diabetic rat.  J Diab Comp. 12 65-73 1998; 
• 6 Haupt E, Ledermann H, Köpcke W. Benfotiamine in treatment of diabetic neuropathy.  J Periph Nerv Syst. 2 270 1997; 
• 7 Horiuchi S, Araki N, Morino Y. Immunochemical approach to characterize advanced glycation end-products of the Maillard reaction. Evidence for the presence of a common structure.  J Biol Chem. 266(12) 7329-7332 1991; 
• 8 Ikeda K, Higashi T, Sano H, Jinnouchi Y, Yoshida M, Araki T, Ueda S, Horiuchi S. N(epsilon)-carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end-products of the Maillard reaction.  Biochemistry. 35 8075-8083 1996; 
• 9 Jermendy G, Noll E, Perényi J, Dworschak E. Thiamine status in NIDDM patients with somatic neuropathy.  Diabetologia 40 ((Suppl 1)) A 561 1997; 
• 10 LaSilva M, Beltramo E, Pagnozzi F, Bena E, Molinatti P A, Molinatti G M, Porta M. Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions.  Diabetologia. 39 1262-1268 1996; 
• 11 Ledermann H, Wiedey K D. Behandlung der manifesten diabetischen Polyneuropathie. Therapeutische Wirkung des neurotropen Vitamin-B-Komplexes B₁-B₆-B₁₂.  Therapiewoche. 39 1445-1449 1989; 
• 12 Netzel M. Zur Verfügbarkeit, Metabolisierung und Wirkung von S-Benzoylthiamin-O-Monophosphat während und nach einer chronischen Äthanolzufuhr. Untersuchungen am Tiermodell Inaugural-Dissertation, Universität Giessen. Wiss. Fachverlag Giessen 1997
• 13 Niwa T, Katsuzaki T, Miyazaki S, Miyazaki T, Ishizaki Y, Hayase F, Tatemichi N, Takei Y. Immunohistochemical detection of imidazolone, a novel advanced glycation end-product, in kidneys and aortas of diabetic patients.  J Clin Invest. 99 1272-1280 1997; 
• 14 Reiners K H, Haupt S. Die Wirkung der Vitamine B1, B6 und B12 auf den Einbau von Cholin in den Ischiasnerv des Kaninchens.  Vitaminspur. 11 74-84 1996; 
• 15 Schreeb K H, Freudenthaler S, Vormfelde S V, Gundert-Remy U, Gleiter C H. Comparative bioavailability of two vitamin B₁ preparations: benfotiamine and thiamine mononitrate.  Eur J Clin Pharmacol. 52 319-320 1997; 
• 16 Sima A AF, Sugimoto K. Experimental diabetic neuropathy: an update.  Diabetologia. 42 773-788 1999; 
• 17 Stracke H, Lindemann A, Federlin K. A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy.  Exp Clin Endocrinol Diabetes. 104 311-316 1996; 
• 18 Vlassara H, Brownlee M, Cerami A. Nonencymatic glyocosylation of peripheral nerve protein in diabetes mellitus.  Proc Natl Acad Sci USA. 78 5190-5192 1981; 
• 19 Vlassara H, Brownlee M, Cerami A. Excessive nonencymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats.  Diabetes. 32 670-674 1983; 
• 20 Ziems M, Netzel M, Rampach C, Jaworski A, Bitsch I. Untersuchungen zur Biokinetik des Benfotiamins beim Menschen.  Zeitschr f Ernährungswiss. 35 95-96 1995; 
• 21 Ziems M. Zur Biokinetik des S-Benzoylthiamin-O-Monophosphats bei gesunden Männern. Analyse mit Metaboliten-Modellen Inaugural-Dissertation, Universität Giessen, Wiss. Fachverlag Giessen 1997